Stocks · Health care · Pharmaceutical Preparations

Cingulate Inc.

CING Clue Score34
United States Fiscal year ends December CIK 0001862150 Results filed 13 Aug 2026

What the insiders did Net buying

By person

12 insiders · 48 transactions
0.1×

Shane J. Schaffer holds only 0.1 times base salary in stock. $71.83K of shares against $479.53K in salary for 2025.

Salary from the company's own proxy. The shares are what Shane J. Schaffer last reported holding, valued at $5.04, the price Common Stock was last bought or sold at on the open market here, on 13 Feb 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Peter J. Werth
Director
$1.29M (6)
—
+$1.29M
117,449
$591.94K
—
Thomas Jeffrey Hargroves
Director
$490.27K (2)
—
+$490.27K
105,768
$533.07K
+54,988%
Gregg Wm Givens
Director
$163.84K (10)
—
+$163.84K
164,318
$828.16K
—
Jennifer L. Callahan
EVP and CFO
$73.46K (11)
—
+$73.46K
13,961
$70.36K
—
Shane J. Schaffer
Chief Executive Officer
$59.63K (5)
—
+$59.63K
14,251
$71.83K
—
Horn Louis G Van
EVP and CFO
$20.04K (1)
—
+$20.04K
15,000
$75.60K
—
Craig S. Gilgallon
EVP and General Counsel
$11.23K (2)
—
+$11.23K
9,550
$48.13K
—
Matthew Brams
EVP and Chief Medical Officer
$9.81K (1)
—
+$9.81K
8,157
$41.11K
+201.0%
Curtis Medeiros
Director
$24.76K (1)
$22.21K (1)
+$2.56K
0
$0.00
—
Laurie Myers
EVP and COO
$2.97K (5)
$841.33 (1)
+$2.13K
0
$0.00
—
Raul R. Silva
EVP and CSO
—
—
—
4,645
$23.41K
+138.6%
Nilay Dahyabhai Patel
EVP, CLO and CCO
—
—
—
3,389
$17.08K
—

No percentages here. This company's share count has moved by a factor of 3.9 over the window, from 3,768,400 to 14,541,826 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.